Study of Ataluren (PTC124™) in Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00803205
Recruitment Status : Completed
First Posted : December 5, 2008
Last Update Posted : June 6, 2017
Cystic Fibrosis Foundation Therapeutics
Information provided by (Responsible Party):
PTC Therapeutics